DiaMedica Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business HighlightsBusiness Wire • Thursday
DiaMedica Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Business Update November 13, 2026Business Wire • 11/05/26
DiaMedica Therapeutics Announces Enrollment of 200th Patient in ReMEDy2 Phase 2/3 Acute Ischemic Stroke TrialBusiness Wire • 10/22/26
DiaMedica Therapeutics Provides Update on Fetal Growth Restriction Key Opinion Leader WebinarBusiness Wire • 10/19/26
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction Featuring Early Phase 2 FGR ResultsBusiness Wire • 09/30/26
DiaMedica Therapeutics to Participate in Upcoming September Investor ConferencesBusiness Wire • 09/02/26
Wall Street Analysts Think DiaMedica Therapeutics (DMAC) Could Surge 129.97%: Read This Before Placing a BetZacks Investment Research • 08/26/26
All You Need to Know About DiaMedica Therapeutics (DMAC) Rating Upgrade to BuyZacks Investment Research • 08/13/26
DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business HighlightsBusiness Wire • 08/10/26
DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026Business Wire • 08/04/26
DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth RestrictionBusiness Wire • 06/23/26
DiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026Business Wire • 05/27/26
DiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke TrialBusiness Wire • 05/20/26
DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare ConferenceBusiness Wire • 05/12/26
DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business HighlightsBusiness Wire • 05/06/26
DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026Business Wire • 04/30/26
DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business HighlightsBusiness Wire • 03/30/26
Top Wall Street Forecasters Revamp DiaMedica Therapeutics Expectations Ahead Of Q4 EarningsBenzinga • 03/30/26
DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026Business Wire • 03/23/26